Related Experiment Video

Updated: May 31, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

Role of polyamines in determining the cellular response to chemotherapeutic agents: modulation of protein kinase CK2

Jan N Kreutzer1, Birgitte B Olsen, Karolina Lech

  • 1Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark.

Molecular and Cellular Biochemistry
|July 14, 2011
PubMed

Insights

Platinum drugs combined with polyamine analogs like N(1),N(11)-diethylnorspermine (DENSPM) show anti-cancer effects. This study found that oxaliplatin and DENSPM together impair cell viability, especially in colorectal cancer cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Platinum compounds and polyamine analogs exhibit anti-proliferative and apoptotic effects.
  • Cancer cells, including pancreatic cancer, often have high polyamine levels, making polyamine depletion a potential anti-tumor strategy.
  • Protein kinase CK2 is a pro-survival enzyme regulated by intracellular polyamines.

Purpose of the Study:

  • To investigate the cytotoxic effects of oxaliplatin combined with polyamine catabolism stimulators in pancreatic and colorectal cancer cells.
  • To determine the impact of combined N(1),N(11)-diethylnorspermine (DENSPM) and oxaliplatin treatment on protein kinase CK2 mRNA and protein levels.

Main Methods:

  • Treatment of human pancreatic and colorectal cancer cells with oxaliplatin and DENSPM, individually and in combination.
  • Assessment of cell viability and cytotoxicity.
  • Analysis of protein kinase CK2 mRNA and protein expression levels.

Main Results:

  • Combined oxaliplatin and DENSPM treatment significantly impaired cell viability, particularly in colorectal cancer cells.
  • The study observed effects on protein kinase CK2 expression, suggesting a link between polyamine metabolism and CK2 regulation.
  • Treatment responses appear to be dependent on the impact of individual compounds on pro-survival and pro-death proteins.

Conclusions:

  • Combined treatment with oxaliplatin and DENSPM demonstrates cytotoxic potential against cancer cells, notably colorectal cancer.
  • The modulation of protein kinase CK2 by this combined therapy warrants further investigation.
  • Careful evaluation of treatment effects on cellular signaling pathways is crucial for future clinical applications.

More Related Videos

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...